Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
2.2
-370.03%
Never
—
39x
60%
—
5 Years
Score2.2
Net Growth-370.03%
Net TrendNever
Net Income Consistency—
Rev Growth39x
Rev Trend60%
Revenue Consistency—
Crinetics Pharmaceuticals Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 71K to $ 7M and net income went from -$ 72M to -$ 465M. Revenue increased in 3 of those 5 years; net income in 0.
Crinetics Pharmaceuticals Inc currently holds a 5-year HDB Score of 2.2 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 84.46 | — |
1 Year2025-08-12 | $ 28.48 | 196.56% |
5 Years2021-08-12 | $ 19.96 | 323.15% |
All Time2018-07-18 | $ 24.51 | 244.59% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2018-07-18 |
|---|---|---|---|---|
| Price | $ 84.46 | $ 28.48 | $ 19.96 | $ 24.51 |
| Return | — | 196.56% | 323.15% | 244.59% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 42M | -$ 501M | $ 1.20B |
| 2025 | $ 7M | -$ 465M | $ 1.02B |
| 2024 | $ 1M | -$ 298M | $ 1.35B |
| 2023 | $ 4M | -$ 214M | $ 558M |
| 2022 | $ 4M | -$ 159M | $ 334M |
| 2021 | $ 1M | -$ 106M | $ 333M |
| 2020 | $ 71K | -$ 72M | $ 170M |
| 2019 | $ 1M | -$ 49M | $ 118M |
| IPO2018 | $ 2M | -$ 27M | $ 163M |
Explore beyond CRNX
You're looking at Crinetics Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
